Pathophysiology of hemolytic transfusion reactions

Seminars in Hematology

Volumn 42, Issue 3, 2005, Pages 165-168

  Davenport, Robertson D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AFELIMOMAB; ECULIZUMAB; ETANERCEPT; INFLIXIMAB; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION REACTION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; HUMORAL IMMUNITY; IMMUNITY; INFLAMMATION; PATHOPHYSIOLOGY; PHAGOCYTE; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANEMIA, HEMOLYTIC; BLOOD TRANSFUSION; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HEMOLYSIS; HUMANS; IMMUNITY; INFLAMMATION;

EID: 22544481422     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2005.04.006     Document Type: Article

References (19)

1. S.J. Ruegg, T.W. Jungi Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells Immunology 63 1988 513 520
2. R.G.Q. Leslie Immunoglobulin and soluble immune complex binding to phagocyte Fc receptors Biochem Soc Trans 12 1984 743 746
3. R.D. Davenport, S.L. Kunkel IgG receptor roles in red cell binding to monocytes and macrophages Transfusion 34 suppl 1994 79S (abstr)
4. J.C. Unkeless Function and heterogeneity of human Fc receptors for immunoglobulin G J Clin Invest 83 1989 355 361
5. S.B. Clarkson, R.P. Kimberly, J.E. Valinsky, M.D. Witmer, J.B. Bussel, R.L. Nachman Blockade of clearance of immune complexes by anti-Fc gamma receptor monoclonal antibody J Exp Med 164 1986 474 489
6. J. Butler, D. Parker, R. Pillai, D.J. Shale, G.M. Rocker Systemic release of neutrophil elastase and tumour necrosis factor alpha following ABO incompatible blood transfusion Br J Haematol 79 1991 525 526
7. R.D. Davenport, R.M. Strieter, S.L. Kunkel Red Cell ABO Incompatibility and production of tumour necrosis factor-alpha Br J Haematol 78 1991 540 544
8. R.D. Davenport, S.L. Kunkel Leukocyte procoagulant activity induced by ABO incompatibility Transfusion 34 suppl 1992 53S (abstr)
9. R.D. Davenport, M. Burdick, S.L. Kunkel Endothelial cell activation in hemolytic transfusion reactions Transfusion 34 suppl 1992 53S (abstr)
10. R.D. Davenport, R.M. Strieter, T.J. Standiford, S.L. Kunkel Interleukin-8 production in red blood cell incompatibility Blood 76 1990 2439 2442
11. R.D. Davenport, M.D. Burdick, R.M. Strieter, S.L. Kunkel Monocyte chemoattractant protein production in red cell incompatibility Transfusion 34 1994 16 19
12. R.D. Davenport, M. Burdick, S.A. Moore, S.L. Kunkel Cytokine production in IgG mediated red cell incompatibility Transfusion 33 1993 19 24
13. M. Hoffman Antibody-coated erythrocytes induce secretion of tumor necrosis factor by human monocytes A mechanism for the production of fever by incompatible transfusions Vox Sang 60 1991 184 187
14. I. Von Zabern, M. Ehlers, U. Grunwald, K. Mauemann, A. Greinacher Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D Transfusion 38 1998 459 468
15. R.D. Davenport, M.D. Burdick, R.M. Strieter, S.L. Kunkel In vitro production of Interleukin-1 receptor antagonist in IgG mediated red cell incompatibility Transfusion 34 1994 297 303
16. M.D. Coopamah, J. Freedman, J.W. Semple Anti-D initially stimulates and Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist Blood 102 2003 2862 2867
17. R.D. Davenport, T.J. Polak, S.L. Kunkel White cell-associated procoagulant activity induced by ABO incompatibility Transfusion 34 1994 934 949
18. P. Hillmen, C. Hall, J.C.W. Marsh Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria N Engl J Med 350 2004 552 559
19. E.A. Panacek, J.C. Marshall, T.E. Albertson Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels Crit Care Med 32 2004 2173 2182